Holding(s) in Company

RNS Number : 1103K

Mediclinic International plc

06 April 2018

 



Mediclinic International plc

(Incorporated in England and Wales)

Company Number 8338604

LSE Share Code: MDC

JSE Share Code: MEI

NSX Share Code: MEP

ISIN: GB00B8HX8Z88

LEI: 2138002S5BSBIZTD5I60

6 April 2018

Notification of Major Interest in Mediclinic International plc shares

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:			MEDICLINIC INTERNATIONAL PLC
1b. Please indicate if the issuer is a non-UK issuer  (please mark with an "X" if appropriate)
Non-UK issuer
2. Reason for the notification (please mark the appropriate box or boxes with an "X")
An acquisition or disposal of voting rights						X
An acquisition or disposal of financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Details of person subject to the notification obligation
Name			PUBLIC INVESTMENT CORPORATION SOC LIMITED
City and country of registered office (if applicable)			PRETORIA, SOUTH AFRICA
4. Full name of shareholder(s) (if different from 3.)
Name			N/A
City and country of registered office (if applicable)
5. Date on which the threshold was crossed or reached:			05/04/2018
6. Date on which issuer notified (DD/MM/YYYY):			06/04/2018
7. Total positions of person(s) subject to the notification obligation
	% of voting rights attached to shares (total of 8. A)	% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)		Total of both in % (8.A + 8.B)	Total number of voting rights of issuer
Resulting situation on the date on which threshold was crossed or reached	7.989%			7.989%	737 243 810
Position of previous notification (if applicable)	8.064%			8.064%

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached
A: Voting rights attached to shares
Class/type of shares ISIN code (if possible)		Number of voting rights					% of voting rights
		Direct (Art 9 of Directive 2004/109/EC) (DTR5.1)		Indirect (Art 10 of Directive 2004/109/EC) (DTR5.2.1)			Direct (Art 9 of Directive 2004/109/EC) (DTR5.1)		Indirect (Art 10 of Directive 2004/109/EC) (DTR5.2.1)
		58 894 769					7.989%
SUBTOTAL 8. A		58 894 769					7.989%
B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))
Type of financial instrument		Expiration date	Exercise/ Conversion Period			Number of voting rights that may be acquired if the instrument is exercised/converted.			% of voting rights
			SUBTOTAL 8. B 1			NIL			NIL
B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))
Type of financial instrument	Expiration date		Exercise/ Conversion Period		Physical or cash settlement			Number of voting rights	% of voting rights
					SUBTOTAL 8.B.2			NIL	NIL

9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an "X")
Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer
Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary)				X
Name	% of voting rights if it equals or is higher than the notifiable threshold	% of voting rights through financial instruments if it equals or is higher than the notifiable threshold	Total of both if it equals or is higher than the notifiable threshold
PUBLIC INVESTMENT CORPORATION SOC LIMITED	7.989%		7.989%
10. In case of proxy voting, please identify:
Name of the proxy holder		N/A
The number and % of voting rights held		N/A
The date until which the voting rights will be held		N/A
11. Additional information
Name: DEVILLIERS MAKONKO E-Mail: Devilliers.Makonko @pic.gov.za TEL: [phone]

Place of completion	PRETORIA, SOUTH AFRICA
Date of completion	06 April 2018

Mediclinic has a primary listing on the Main Market of the LSE in the United Kingdom, with secondary listings on the JSE in South Africa and the NSX in Namibia.

For further information please contact:

Mediclinic International plc

James Arnold, Head of Investor Relations

[e-mail]

[phone]

Company Secretary, Link Company Matters Limited

Victoria Dalby

[phone]

Registered address: 6th Floor, 65 Gresham Street, London, EC2V 7NQ, United Kingdom

Website: www.mediclinic.com 

Corporate broker: Morgan Stanley & Co International plc

JSE sponsor: RAND MERCHANT BANK (A division of FirstRand Bank Limited)

NSX sponsor: Simonis Storm Securities (Pty) Ltd

 

END

 

 

HOLUNOKRWVASRRR